KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Income from Continuing Operations: 2010-2025

Historic Income from Continuing Operations for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to -$35.0 million.

  • Nektar Therapeutics' Income from Continuing Operations rose 5.58% to -$35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.4 million, marking a year-over-year increase of 32.63%. This contributed to the annual value of -$119.0 million for FY2024, which is 56.90% up from last year.
  • As of Q3 2025, Nektar Therapeutics' Income from Continuing Operations stood at -$35.0 million, which was up 10.76% from -$39.2 million recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Income from Continuing Operations ranged from a high of $7.2 million in Q4 2024 and a low of -$159.1 million during Q2 2022.
  • In the last 3 years, Nektar Therapeutics' Income from Continuing Operations had a median value of -$42.1 million in 2023 and averaged -$46.9 million.
  • As far as peak fluctuations go, Nektar Therapeutics' Income from Continuing Operations crashed by 56.90% in 2021, and later soared by 117.19% in 2024.
  • Nektar Therapeutics' Income from Continuing Operations (Quarterly) stood at -$146.9 million in 2021, then skyrocketed by 54.66% to -$66.6 million in 2022, then skyrocketed by 36.82% to -$42.1 million in 2023, then spiked by 117.19% to $7.2 million in 2024, then rose by 5.58% to -$35.0 million in 2025.
  • Its Income from Continuing Operations was -$35.0 million in Q3 2025, compared to -$39.2 million in Q2 2025 and -$46.4 million in Q1 2025.